Psychiatry’s Biggest Paradigm Shift Is Happening Now #ibogaine #psychedelicmedicine #ptsd #therapy
WATCH THE FULL VIDEO 🟢 ➜ ➜ ▶️ https://youtu.be/-byVXULUmVI
We are experiencing a significant paradigm shift in psychiatry and addiction medicine, moving from theoretical discussions to structured, state-supported programs. This video highlights active federal momentum and existing state-level initiatives, with new programs focused on addiction recovery and severe mental health conditions currently under development. As a psychiatrist and doctor, I am committed to advancing medical education in this crucial area of neuroscience.
🌿⚕️FACEBOOK: www.facebook.com/PodestaPsychiatry
🌿⚕️LINKEDIN: www.linkedin.com/in/arwenpodestamd
🌿⚕️INSTAGRAM: www.instagram.com/doctor.arwen
🌿⚕️CLINIC: https://podestawellness.com
🌿⚕️WEBSITE: https://www.drarwen.com
🌿⚕️BOOK: https://a.co/d/0e6Olm9x
Dr. Arwen Podesta MD, DFASAM, DFAPA is a triple board certified physician specializing in functional psychiatry, addiction medicine, and forensic psychiatry. 🧠
🩺#ClinicalPsychiatry, #functional psychiatry, #drpodesta
🩺#MentalHealth, #BehaviorChange, #BrainChemistry
🩺#Neurobiology #Psychiatry #forensicpsychiatry
🩺#AddictionRecovery, #NervousSystem
Full Transcript
Paradigm Shift in Psychiatry and Addiction Medicine 0:00
There is a big picture shift. We're in the middle of a paradigm shift in psychiatry and addiction medicine. So, y'all, this is not fringe anymore. This is structured, state-supported medicine in development. Seriously, the real deal is that this no longer theoretical. We now have active federal momentum, multiple state-level programs already live, and states like Louisiana building the next wave focused specifically
Federal Momentum and State Programs 0:24
on addiction and severe psychiatric illness. And this is one of the strongest signals that we've seen in psychiatry in decades, certainly in my career. Because if this becomes a legitimate treatment, we can't rely on stripping a rare plant from Central and West Africa to meet a global demand. Now, pharmacologically, Ibogaine is very different from other psychedelics. It's what we call polypharmacologic.
Ibogaineu2019s Unique Pharmacology 0:52
it works across multiple systems. And honestly, this multitude of efficacy is part of the beauty of whole plant medicine. And this is where one of strongest arguments for the legislation is something that we are super excited about. We need pharmaceutical-grade synthesis, standardized production, regulated clinical environments.
Need for Standardized, Ethical Production 1:19
So when we talk about Ibogaine, we're really talking about three simultaneous challenges. clinical efficacy, which is quite promising, medical safety, not something to sneeze at, and sustainability and ethical production, absolutely essential for the future. The biggest mistake I'm seeing right now is patients, providers and the general community thinking, I'll just wait for psychedelics because they're on
Why Delaying Treatment Can Be Dangerous 1:48
their way, right? Be sure, though, that delay can be dangerous.
Comments